Screening the Low Molecular Weight Fraction of Human Serum Using ATR-IR Spectroscopy by Bonnier, Franck et al.
Technological University Dublin 
ARROW@TU Dublin 
Articles NanoLab 
2016-06-01 
Screening the Low Molecular Weight Fraction of Human Serum 
Using ATR-IR Spectroscopy 
Franck Bonnier 
Université François-Rabelais de Tours 
Matthew J. Baker 
University of Strathclyde 
Hugh J. Byrne 
Technological University Dublin, hugh.byrne@tudublin.ie 
Follow this and additional works at: https://arrow.tudublin.ie/nanolart 
 Part of the Analytical, Diagnostic and Therapeutic Techniques and Equipment Commons, and the 
Medicinal-Pharmaceutical Chemistry Commons 
Recommended Citation 
Byrne, H. et al. (2016) Screening the low molecular weight fraction of human serum using ATR-IR 
spectroscopy. Journal of Biophotonics, 9, 1085-1097 (2016) doi:10.1002/jbio.201600015 
This Article is brought to you for free and open access by 
the NanoLab at ARROW@TU Dublin. It has been accepted 
for inclusion in Articles by an authorized administrator of 
ARROW@TU Dublin. For more information, please 
contact yvonne.desmond@tudublin.ie, 
arrow.admin@tudublin.ie, brian.widdis@tudublin.ie. 
This work is licensed under a Creative Commons 
Attribution-Noncommercial-Share Alike 3.0 License 
  Copyright line will be provided by the publisher 
Journal header will be provided by the publisher   
Screening the low molecular weight fraction of human serum using ATR-IR 
spectroscopy 
 
Franck Bonnier,*,1, Guillaume Brachet2, Romain Duong1, Tobiloba Sojinrin3, Renaud Respaud4, Nicolas Aubrey5,6, Matthew J. 
Baker6, Hugh J. Byrne3, Igor Chourpa1 
 
1 Université François-Rabelais de Tours, Faculty of Pharmacy, EA 6295 Nanomédicaments et Nanosondes, 31 avenue Monge, 37200 
Tours, France. 
2 Université François Rabelais de Tours, UMR CNRS 7292 Génétique, Immunothérapie, Chimie et Cancer, Faculté de Médecine, 10 
Bd Tonnellé, 37032 Tours Cedex 
3 FOCAS Research Institute, Dublin Institute of Technology (DIT), Camden Row, Dublin 8, Ireland 
4 Université François-Rabelais de Tours, UMR 1100, CHRU de Tours, Service de Pharmacie, F-37032 Tours, France 
5 Université de Tours, UMR1282 Infectiologie et Santé Publique, 37200 Tours, France 
6 Institut National de la Recherche Agronomique, UMR1282 Infectiologie et Santé Publique, 37380 Nouzilly, France 
7 WestCHEM, Technology and Innovation Centre, Department of Pure and Applied Chemistry, University of Strathclyde, 295 
Cathedral Street, Glasgow G1 1XL, UK 
 
 
Received zzz, revised zzz, accepted zzz 
Published online zzz 
Key words: Human serum, centrifugal filtration, IR spectroscopy, Attenuated Total Reflection (ATR), Principal Component 
Analysis, Low Molecular Weight Fraction (LMWF) 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revealing serum LMWF for spectral serological diagnostic 
applications 
Vibrational spectroscopic techniques can detect small 
variations in molecular content, linked with disease, showing 
promise for screening and early diagnosis. Biological fluids, 
particularly blood serum, are potentially valuable for 
diagnosis purposes. The so-called Low Molecular Weight 
Fraction (LMWF) contains the associated peptidome and 
metabolome and has been identified as potentially the most 
relevant molecular population for disease-associated 
biomarker research. Although vibrational spectroscopy can 
deliver a specific chemical fingerprint of the samples, the 
High Molecular Weight Fraction (HMWF), composed of the 
most abundant serum proteins, strongly dominates the 
response and ultimately makes the detection of minor 
spectral variations a challenging task. Spectroscopic 
detection of potential serum biomarkers present at relatively 
low concentrations can be improved using pre-analytical 
depletion of the HMWF. In the present study, human serum 
fractionation by centrifugal filtration was used prior to 
analysis by Attenuated Total Reflection infrared 
spectroscopy. Using a model sample based on glycine spiked 
serum, it is demonstrated that the screening of the LMWF 
can be applied to quantify blinded concentrations up to 50 
times lower. Moreover, the approach is easily transferable to 
different bodily fluids which would support the development 
of more efficient and suitable clinical protocols exploring 
vibrational spectroscopy based ex-vivo diagnostic tools. 
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1.  Introduction 
Vibrational spectroscopic techniques have been 
extensively evaluated for their capacity to deliver a 
specific molecular fingerprint closely linked to the 
disease state [1-5]. Ranging from tissue to single cell 
analysis, both infrared and Raman spectroscopy are 
promising techniques with potential clinical applications 
[6]. Spectral imaging of biopsies using FTIR or Raman 
confocal micro-spectroscopy has proven the potential of 
these approaches for the identification of pathological 
areas delivering additional histological information for 
diagnosis based on the molecular profiles of the samples. 
Applied to single cell analysis, the specificity of the 
techniques allows in vitro screening of toxicological 
effects of ionising radiation, nanoparticles or the action 
of chemotherapeutic agents at the subcellular level [7-12]. 
Recently, vibrational spectroscopy in the field of spectral 
cytology performed on cervical samples for the detection 
of abnormal cells based on their chemical composition 
has attracted more attention [13, 14]. However, diseases 
such as cancer could remain asymptomatic until they 
reach a stage of development too advanced for effective 
treatment, and therefore routine screening for early 
detection is crucial to improve patient prognosis. In this 
context, bodily fluids are of great interest [15], and, 
although urine or saliva could be attractive candidates for 
patients screening and monitoring [16, 17], blood serum 
remains potentially the most valuable alternative to 
identify reliable biomarkers for diagnosis purposes [18].   
The development of proteomic technologies with 
medical perspectives needs to align with clinical 
requirements such as compatibility with large patient 
cohort analysis, speed and cost effectiveness to enable 
clinical translation of these promising technologies. 
Analysis of human serum for the identification of 
disease-associated biomarkers is a challenging task, with 
numerous obstacles to overcome. For instance, in recent 
studies investigating the feasibility to develop methods 
for proteomic investigation, the high protein content (i.e. 
60–80 mg/ml) could be interpreted as a beneficial 
attribute of the sample [19]. Indeed, with about 25% of 
all proteins encoded by the genome predicted to be 
secreted, serum is a rich source of biochemical products 
that can act as biomarkers of disease or physiological 
status of a patient [20]. It is expected that, by measuring 
concentrations of specific molecular species in the serum, 
the presence of disease associated proteins being secreted 
and shed from cells and tissues can be determined. For 
example, increased serum levels of prostate-specific 
antigen (PSA) and CA125 are routinely used for the in 
vitro detection of cancer in the prostate and ovary in 
clinic routines [21]. However, the main limiting 
characteristic of the serum is the dynamic range of 
concentrations observed between the abundant, high 
molecular weight and the sparse, low molecular weight 
proteins. As a part of the high molecular weight fraction 
(HMWF), proteins such as human serum albumin (HSA) 
(57–71%) and globulins (8–26%), completely dominate 
the composition of the serum quantitatively but only 
account for 0.1% of the total number of protein species. 
Consequently, many potentially important molecules and 
markers can escape detection, due to difficulties in 
monitoring the smaller, less abundant serum constituents. 
For example, proteolysis within the tissue or deregulated 
post-translational events participate in fragmentation of 
proteins produced in the tumors that diffuse into the 
circulation [22]. Disease biomarkers are often low-
molecular-weight proteins/peptides, exhibiting far 
greater tumor and vascular permeability due to their 
molecular size range, and are thus secreted into the 
bloodstream as a result of the disease process. The Low 
molecular weight fraction (LMWF) (≤ 25 kDa) plasma 
or serum proteome has been the focus of recent attempts 
to identify novel diagnostic and prognostic cancer 
biomarkers [23, 24]. The LMWF holds much promise for 
identification of diagnostics or prognostic markers, 
further supported by recent associations of pathological 
conditions with small protein and peptide profiles in 
serum, notably for diabetes [25], cardiovascular or 
infectious diseases [26]. The analytical capabilities of 
traditional proteomic methods are limited given the large 
dynamic range of concentrations in the serum. Therefore, 
depletion of the highly abundant proteins is now 
recognized as the first step, yet to be optimized, in the 
analysis of the serum proteome. A key challenge in 
identifying constituents in the LMWF in the serum is to 
overcome the 10 orders of magnitude concentration 
difference between the least abundant (interleukins, 
cytokines < 5 pg/mL) and the most abundant (albumin: 
up to 60 mg/mL).  
Infrared and Raman spectroscopy have great potential for 
serum based detection of disease biomarkers in serum 
[27, 28]. However, the techniques suffer from similar 
limitations to those encountered with chromatography 
and/or mass spectroscopy based approaches. Highly 
abundant proteins can strongly dominate the data 
collected, making it difficult to detect small variations in 
the features related to the presence of the informative 
low molecular weight proteins/peptides [29]. This 
present study details a proof of concept approach, 
combining centrifugal filtration with Attenuated Total 
Reflection infrared (ATR-IR) spectroscopy for the 
detection of glycine (selected as a small model 
biomolecule/biomarker) within the complex human 
serum mixture. The filtration approach is an attractive 
alternative to time consuming separation techniques such 
as chromatography, offering a rapid and specific 
fractionation of proteins according to molecular weight 
without the need for chemical extraction that could affect 
the spectral profiles recorded. The spectroscopic 
approach is demonstrated as a highly sensitive, label free 
method of detecting and quantifying the small molecule 
within the LMWF. 
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2.  Experimental  
2.1 Sample preparation 
 
Sterile filtered human serum from normal mixed pool 
(off the clot) was donated by the University Hospital 
CHU Angers (France) as part of the Cancéropôle du 
Grand-Ouest consortium. Commercially available 
centrifugal filtering devices, Amicon Ultra-0.5ml 
(Millipore - Merck, Germany), with cut-off points at 10 
kDa, were employed in this study, as an illustrative 
example. As a result, 2 fractions were obtained following 
filtration; the first representing proteins with a molecular 
weight higher than the cut off point of the filter used 
(concentrate); the second corresponding to the fraction 
passed by the membrane and collected in the vial 
(filtrate). The serum was 1:10 diluted in distilled H2O 
prior to processing, 0.5 mL of the solution being placed 
in the centrifugal filter for spinning, in order to minimize 
any potential effects of mechanical strain and clogging 
on the filter membrane. The procedure for washing the 
centrifugal devices prior to serum analysis was adapted 
from [30], based on manufacturer’s guidelines, and 
performed as follows: The Amicon Ultra-0.5ml filter was 
spun thrice with a solution of NaOH (0.1M), followed by 
3 rinses with Milli-Q water (Millipore Elix S). For both 
washing and rinsing, 0.5 mL of the respective liquid was 
added to the filters and the centrifugation was applied for 
10 mins at 14 000g followed by a spinning with the 
devices upside down at 1000g for 2 mins in order to 
remove any residual solution contained in the filter.  
 
Additionally, Albumin from human serum (Sigma-
Aldrich, Ireland) and glycine (Cooper, France) were 
analysed as reference chemical compounds for the 
evaluation of the centrifugal filtration process. Notably, 
glycine has been selected because it is the smallest 
amino acid, having a molecular weight of 75 Da, which 
results in free diffusion through the membrane of the 
centrifugal filters and can serve as a model for LMWF 
peptides. Firstly, the whole human serum sample has 
been supplemented with known concentrations of 
glycine; 0.0 mg/mL (control), 0.5 mg/mL, 1 mg/mL, 2.5 
mg/mL, 5 mg/mL, 7.5 mg/mL, 10 mg/mL, 17.5 mg/mL, 
25 mg/mL and 50mg/mL, in order to explore the 
dynamic range and sensitivities of the ATR-IR 
measurement of unprocessed samples. Therefore, the 
concentrations has been selected to cover a wide range of 
concentrations from extremely high, non-clinically 
relevant, to relatively low in order to better understand 
and explore the capabilities and behavior of the ATR-IR 
instruments in humans serum monitoring. Secondly, a 
stock solution corresponding to the LMWF, prepared 
following centrifugal filtration with the 10kDa filters, 
has been supplemented with  known concentrations of 
glycine of 0.01 mg/mL, 0.05 mg/mL, 0.1 mg/mL, 0.25 
mg/mL, 0.5 mg/mL, 1 mg/mL, 2 mg/mL and 2.5 mg/mL. 
The serum stock solution without addition of glycine has 
been used as a reference to build the regression models. 
 
2.2 Dry mass measurements 
 
In order to calculate total dry mass of the samples, it is 
necessary to freeze-dry (lyophilize) the samples. Thus, 
freeze drying was performed using a Labonco lyophilizer 
(Freezone, USA), whereby the vials have been placed 
overnight at -51°C and under vacuum (<0.05 mBar). 
This procedure has been applied on sets of whole human 
serum (n =3) and following ultrafiltration with a 10kDa 
filter (n=3) to estimate to overall dry mass but also 
determine the amount of biological material recovered in 
the filtrated fractions, corresponding to the LMWF.      
 
2.3 Data collection using the ATR-IR  
ATR-IR spectra were recorded using a Bruker vector 22 
equipped with a UATR module. Sample penetration is 
both wavenumber and sample dependent, but is typically 
on the order of 1µm. Spectral data were the result of 16 
scans, with a spectral resolution of 4 cm
-1
 covering the 
spectral window 4000 – 600 cm-1. A background 
spectrum was also recorded (64 scans) and automatically 
rationed with the sample spectrum by the software.  
 
Whole human serum: The spectroscopic analysis of 
samples was performed directly after deposition of a 
drop on the crystal (0.5 µL, to ensure sample coverage is 
less than the full area of the crystal, minimizing the 
effects of inhomogeneities), while still in liquid form and 
also in a dry state following 10 min air drying prior to 
recording. 10 replicates have been performed for each 
serum sample. 
 
Filtered fraction of the human serum: The relatively 
weak concentrations of the filtrates (LMWF) following 
centrifugal filtrations using a 10kDa filter have been 
found to greatly impact on the spectral data collected. 
The freeze drying process was therefore used to re-
concentrate the molecules present in the LMWF. Based 
on a protocol detailed above, 400 µL of the filtrate were 
processed and the resulting lyophilized material was re-
suspended in distilled water (20 µL). However, the 
recording of IR spectra from the LMWF in the liquid 
form has still been found not relevant due to the signal to 
noise ratio exhibited and only air drying of the drops 
deposited on the crystal has allowed to generate relevant 
data. Similarly to whole human, 0.5 µL has been 
deposited on the crystal and 10 replicates have been 
performed for each sample. 
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2.4 Size exclusion chromatography (SEC) 
SEC was performed on an Alliance e2695 (Waters) 
equipped with both Wyatt miniDawn Treos and Optilab 
T-rEx (Wyatt Technology Europe GmbH) detectors. 50 
µL of each serum sample was injected onto A SHODEX 
KW803 column (300 mm x 7.8 mm) and separated at a 
flow rate of 0.7 mL/minute using PBS (pH 7.2) as 
elution buffer. The PDA 2998 apparatus (Waters) was 
employed for the UV detection at 280 nm, while the 
MALLS detection was performed with a three-angle 
(43.6°; 90.0°; 136.4°) miniDawn Treos detector (Wyatt 
Technology Europe) operating with a 60-mW solid-state 
laser at 658 nm. For consistency, a total elution time of 
25 mins was used for all samples. The whole serum 
being highly concentrated, a 1:50 dilution was prepared 
prior to SEC analysis. In comparison, the LMW filtrates 
were analyzed without any further dilution, since they 
were obtained after centrifugal filtration performed on 
diluted serum (1:10).  
 
2.5 Data pre-processing and analysis 
The different pre-processing and data analysis steps were 
performed using Matlab (Mathworks, USA) with the 
unsupervised attribute of Principal Component Analysis 
(PCA) exploited as an approach to highlight and quantify 
the spectral variability generated by the addition of 
known concentrations of glycine to the human serum.  
The analysis of the spectra collected has been restricted 
to the finger print region where the water contribution is 
less pronounced. While the spectra collected from liquid 
samples have been min-max normalised on the water 
band at 1636 cm
-1
, the spectra collected from the air 
dried whole serum and the filtered samples (LMWF) 
were processed using baseline correction (rubber-band) 
followed by vector normalization. This enabled the 
observation and evaluation of the systemic variations in 
the data following the increased of glycine with the PCA 
analysis. Vector normalization has been found to be 
particularly suitable for this study in order to equalize the 
contribution of the different serum physiological 
constituents in the spectra collected between sets and 
further enhance the systematic variations in the glycine 
features. Ultimately the PCA analysis performed on the 
whole finger print region reflects the evolution of band 
ratios in the data, such that the features of the mixed pool 
serum act as internal standards such that the added 
glycine can be quantified. It should be noted that, for 
each tested condition the lowest concentration of glycine 
prepared (0.5 mg/mL or 0.01 mg/mL) has been excluded 
from the regression model and kept as a blinded sample 
to verify and validate the robustness of the method.     
3.  Results and discussion 
 
3.1 ATR-IR detection of a single model 
biomolecule  
Analysis of molecules using infrared spectroscopy can 
be performed following a number of different set ups, 
depending on the instrumentation available. Most 
traditionally, the spectra are recorded using the 
transmission mode, involving the IR beam passing 
through the sample. However, the ATR (Attenuated 
Total Reflectance) mode is particularly adapted for the 
analysis of highly concentrated liquid samples [31]. 
Notably, the approach does not require expensive 
spectroscopic substrates and the planar, easily washable 
surface offered by the crystal is an advantage for 
repeated measurements. Therefore, a drop can be directly 
deposited onto the crystal, delivering high quality spectra 
without saturation that can be encountered with 
transmission mode measurements [32]. Liquid samples 
can be analysed and characterised using ATR-IR spectra, 
but the sensitivity of the information collected directly 
depends on the concentration of the solution. Figure 1 
presents IR spectra collected from aqueous solutions of 
glycine (200 mg/mL) using the ATR mode of solution 
(‘wet’ sample) (Figure 1A) and following air drying 
(Figure 1B). The limited spectral region of 1800-650cm
-1
 
was chosen to avoid the regions of strong water 
absorption in the liquid samples, and to minimise any 
effects of incomplete drying in dried samples, thus 
enabling better comparison between liquid and dried 
samples. While the spectrum obtained from the solution 
exhibits the specific features of glycine, the contribution 
of the spectrum of deionised water can still be observed 
(dotted line). However, specific features of glycine such 
as CH2 rocking (914 cm
-1
), C-N stretching (1039 cm
-1
), 
N-H3 rocking (1117 cm
-1
), C-H2 wagging (1333 cm
-1
) or 
O-C=O symmetric stretching (1412 cm
-1
) are easily 
identifiable. The band at 1333 cm
-1
 is particularly 
interesting due to its strong relative intensity but also its 
positioning remote from the main water band (1636 cm
-
1
), and is thus used for further analysis in Figure 2. The 
spectrum collected from the solution of glycine 
following air drying (Figure 1B) exhibits notable 
modifications that could result from aggregation and/or 
crystallization effects (e.g. bands between ~1100 – 1150 
cm
-1
). The main spectral features are, however, 
preserved.    
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Figure 1: Typical ATR IR spectrum collected from solution 
(‘wet’ samples) of glycine at 200 mg/mL deposited on the ATR 
crystal (A) and after air-drying (B). No preprocessing has been 
applied. Additionally the dotted line represents the contribution 
of the water to the signal collected from the solution. The 
spectra have been offset for clarity and the main features of 
interest are highlighted in grey.  
 
Figure 2 presents the concentration dependence of the 
area under the curve observed in raw data (AUC – 
between baseline and peak maximum) calculated for the 
band 1360-1280 cm
-1 
from solution of glycine (figure 2 – 
blue) and following air drying (figure 2 - red). Note, the 
spectra have not been normalized. In the case of the 
liquid samples, the thickness of the droplet exceeds the 
penetration depth of the ATR evanescent wave, and the 
systematic increase of the solution concentration results 
in a linear correlation between the concentration of 
glycine and the intensity of the signal (R
2
 = 0.9999), in 
accordance with the Beer-Lambert law. In the dry 
sample, all the dissolved glycine is deposited on the 
crystal surface and therefore is sampled by the 
evanescent wave, resulting in a substantially larger 
absorbance for all concentrations and a steeper initial 
increase in the concentration dependence. However, the 
linearity of the measurement response is lost when the 
thickness of the dried sample exceeds the depth of 
penetration of the evanescent wave. Therefore, as seen in 
figure 2 (red dots), above 25 mg/mL there is a saturation 
of the IR absorbance. Indeed, this effect can only be 
clearly seen in unprocessed data collected from dry 
samples, as the commonly employed normalization steps 
of the preprocessing protocol would compensate for the 
loss of intensity in the spectra. However, the 
observations highlight the fact that, following air drying, 
the Beer-Lambert type dependence of the absorbance on 
concentration and length of the optical path are both 
partially lost and the critical parameter is the amount of 
matter deposited. Thus, while a linear dependence of the 
absorbance is observed over a wider range for the liquid 
samples, for the dried samples, increased sensitivity is 
achievable at the lower end of the concentration range. 
 
 
Figure 2: Evolution of Area Under the Curve (AUC) of the 
band 1360-1280 cm-1 as a function of glycine concentrations. 
The blue squares represent the measurement performed from 
the sample in liquid form while the red dots correspond to the 
samples deposited after air-drying. The dotted line represents a 
linear fit to the liquid form data. 
 
 
3.2 Analysis of human blood serum  
Although recording reproducible IR spectra from human 
serum could appear an easy task due to the particularly 
high concentration of protein content, specificity towards 
detection of minority species could be severely limited 
because of the complexity of the signal collected. 
Although human serum is naturally highly concentrated, 
spectra collected for the liquid form are still dominated 
by the water contribution (Figure 3A). In contrast, the 
water free spectrum collected after air drying (Figure 3B) 
displays numerous well defined peaks within the 4000-
650 cm
-1
 spectral widow, allowing clearly identification 
of specific features of the human serum, for example 
those highlighted in grey at 3280 cm
-1 
 (H–O–H 
stretching), 2957 cm
-1 
(Asymmetric CH3 stretching), 
2920 cm
-1 
 (Asymmetric CH2 stretching), 2872 cm
-1 
 
(Symmetric CH3 stretching), 1536 cm
-1 
(Amide II of 
proteins), 1453 cm
-1 
(CH2 scissoring), 1394 cm
-1 
(C=O 
stretch of COO–), 1242 cm-1  (Asymmetric PO2 stretch), 
1171 cm
-1 
(Ester C–O asymmetric stretch) and  1080 cm-1 
(C–O stretch) [33-35]. However, the dried serum 
spectrum is very similar to the spectrum collected from 
similarly dried human serum albumin (HSA), as a result 
of its high concentration in human serum (Figure 3D). 
This example perfectly illustrates the spectral dominance 
that can be observed from the contributions of the 
abundant proteins of the HMWF (Figure 3C). The 
spectra of these proteins swamp the contribution of less 
represented biomolecules, raising the question to 
whether or not minor variations of minority components 
can be detected and quantified.    
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Figure 3: Typical ATR IR spectrum of a 5 mg/mL air dried 
human serum albumin solution (A) compared to the HMWF 
concentrated with a 10kDa filter (B); the human unfiltered 
serum following air drying (C) and in its liquid form (D). 
Spectra have been offset for clarity with the main features 
highlighted in grey. No spectral preprocessing has been 
applied. 
 
3.3 Detection of Molecules in human serum  
In order to build a model to mimic variations that could 
naturally occur in the LMWF, pure lyophilized glycine 
has been added at known and variable concentrations to 
human serum. Following the collection of ATR-IR 
spectra, the capabilities of the technique have been 
evaluated through the monitoring of systematic spectral 
modifications in the data sets, despite the presence of 
dominant HMW proteins.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thus, a wide range of concentrations has been used for 
the analyses which have been performed in both liquid 
and dried forms, in order to evaluate the sensitivity and 
determine the specificity offered by the experimental set 
up used. Concentrations covering the range 0.5 mg/ml to 
50 mg/mL have been found most suited to illustrate the 
capabilities of the ATR-IR toward whole human serum 
analysis. Although the concentrations used for 
illustration are not necessarily physiologically relevant, 
the limits of the tested range have been purposely 
extended in order to offer better appreciation of the 
spectral behavior for various amounts of glycine. The 
mean IR spectra collected from the different samples 
prepared (liquid) are presented in figure 4A, organized 
from bottom to top according to the concentrations of 
glycine added to the whole human serum, and off-set for 
clarity. A stock solution of human mixed pool serum has 
been used in this study in order to have a consistent basis 
for the preparation of the samples and ensuring that the 
chemical composition only varies based on the added 
quantities of glycine. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: A: Mean ATR-IR spectra collected from 
unprocessed whole human serum (a) and supplemented with 
0.5 mg/mL, 1 mg/mL, 2.5 mg/mL, 5 mg/mL, 7.5 mg/mL, 10 
mg/mL, 17.5 mg/mL, 25 mg/mL and 50 mg/mL of glycine 
(respectively b-j)- Spectra offset for clarity; B: Scatter plot 
from the PCA performed on ATR-IR spectra collected from the 
different solutions. Colour coding has been used to better 
identify the different groups of spectra. The top arrow indicates 
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the distribution of the data across the scatter plot according to 
concentrations of glycine added; C: Loadings 1 and 2 
corresponding to the PCA analysis performed on serum 
solutions (respectively blue and red); D: Linear regression fit of 
ATR-IR absorption versus concentration of glycine in whole 
human serum in solution. The plot represents the distance 
between each groups and the un-supplemented serum (0 
mg/mL) calculated using the PC_1 score from the PCA. 
 
The data collected from the samples have been analyzed 
by Principal Component Analysis (PCA), delivering, in 
an unsupervised fashion, the variance between the data 
sets, either graphically with the scatter plot or through 
the loadings expressing the discriminating spectral 
features [36]. The results corresponding to the PCA 
performed on spectra collected from the liquid samples 
supplemented with glycine compared to the un-
supplemented serum stock solution are presented in 
figure 4B. The distribution along the PC 1 axis is directly 
related to the variation of concentration of glycine added 
to the human serum, an observation confirmed by the 
loading of PC1, accounting for 98.12% of the variance 
and displayed in figure 4C.  
 
While a clear discrimination between the different 
clusters can be seen at the highest concentrations (figure 
4B top arrow), the degree of separation is strongly 
reduced when the concentrations of glycine added are 
below 10 mg/mL, especially for the 2.5 mg/mL (yellow 
dots), 1 mg/mL (blue dots) and 0.5 mg/mL (green dots).      
PC 2 only accounts for 0.58% of variance which 
indicates quite minor variations in the spectra collected. 
The spectral profile of PC2 (Figure 4B) does not clearly 
correlate with the glycine spectrum. The positions of the 
different clusters formed by the spectra along the PC 2 
axis are, however, not correlated with the concentration 
of glycine and the inter and intra cluster variability could 
thus be attributed to instrumental or experimental 
variability.  
While the loading of PC 1 exhibits a spectral profile 
identical to the pure solution of glycine (figure 1A), the 
loading of PC 2 (figure 4Cb) is particularly noisy and 
does not exhibit any clear features which can be 
unambiguously related to spectral features of glycine 
(data not shown). This is further supported by the 0.58% 
of variance expressed by PC 2, clearly highlighting the 
absence of relevant discriminative information along this 
PC. It should be noted that, in order to remove the tail 
effect visible in figure 4A due to the presence of water in 
the liquid samples, the PCA analysis has been performed 
on the range 1800-1000 cm
-1
.  
PCA remains a powerful tool, widely employed for data 
mining and in particular for studies aiming to 
discriminate data groups for diagnostic purposes [36]. 
The chemical information obtained from the loadings 
allows correlation of the distribution of the data points 
across the scatter plot with specific variations in the 
spectra, and, in this instance, to confirm the contribution 
of the glycine signature to the observed variance. 
Moreover, the location of each spectrum in the 
scatterplot is defined by scores along both PC 1 and PC 2 
(figure 4B) which can be assimilated to coordinates 
positioning the groups with respect to each other. 
Therefore, the most different spectra, according to a 
specific PC, will be separated by a greater distance than 
those exhibiting stronger similarities. Ultimately, when 
the limit of specificity of the information contained in 
the spectra has been reached, no more discrimination 
would be discernible on the scatter plot, meaning that, 
score wise, the spectra would be characterized by similar 
values along the relevant PC.  
 
To represent this, firstly, the mean score values for each 
tested concentration of glycine are evaluated for PC 1 
using Mi = ∑scores/ni (with ni = number of spectra for a 
given concentration). Secondly, the distance between 
each group and the un-supplemented serum (0 mg/mL) 
has been calculated (∆PC = Mi – M0 mg/mL). Finally, the 
degree of separation has been expressed using Eq.1: 
 
xi = (∆PC_1i
2
)
1/2
                          (1) 
(i: different concentrations tested ) 
 
Considering the case of liquid human serum, PC 2, 
accounting for only 0.58% of the variance, can be 
disregarded, as there is no clear correlation with the 
systematic change in concentration. Finally, the values 
calculated can be plotted against the different 
concentrations of glycine added in the whole serum, as 
presented in figure 4D. The results for the analysis of 
liquid samples display acceptable linearity (R
2 
= 0.9993). 
Note that the regression model has been built without 
taking onto account the lowest concentration, 0.5 
mg/mL, which has been then used as a blinded sample to 
evaluate the sensitivity of the methods. Accordingly, the 
10 replicates from the 0.5 mg/mL sample have been 
inputted into the regression model giving an average 
predicted value of 0.45 mg/mL +/- 0.16 mg/mL.  
In order to better evaluate the impact of working from 
liquid serum samples, the drops deposited on the ATR 
crystal have been air dried before recording in order to 
collect water free spectra. The resulting mean spectra are 
displayed in figure 5A, and the corresponding results 
from the PCA are presented in figure 5B, 5C and 5D. 
The absence of water bands greatly improves the 
visibility of the different features resulting from both the 
human serum constituents and the added glycine. The 
distribution of the different groups of spectra on the 
scatter plot follows a different pattern, both PC 1 and PC 
2 being influenced by the presence of the glycine. As a 
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consequence, the loadings 1 and 2 exhibit similar 
spectral features of this model amino acid and they 
respectively account for 98.2% and 1.4% of the 
explained variance. However, the spectra collected from 
the samples supplemented with 50 mg/mL glycine have 
been considered as outliers and excluded from the data 
set to build the regression model. It appears that such 
high concentration generated a quite different spectral 
profile, potentially due to aggregation, leading to 
difficulties in interpreting the peak position and intensity 
compared to lower concentrations (figure 5A). 
 
Therefore, although the PC 2 expresses 1.4% of the 
explained variance it has been considered that most were 
related to the position of the 50 mg/mL spectra. Finally, 
only the PC 1 was used for the calculation of the degree 
of separation between the different clusters formed on 
the scatter plot, as described in equation (1).      
The curve obtained from the PC 1 score according to 
Equation 1 exhibits quite a different profile compared to 
the liquid samples, as seen in figure 5D, with a deviation 
from linearity apparent above ~ 10mg/mL, similar to the 
case for dried glycine in Figure 1. The relationship 
between the glycine concentration in the serum and the 
variations observed in the spectra can be expressed by 
means of a polynomial fitting, giving a R
2
 value of 
0.9978. Polynomial expansions are common in the 
mathematical description of many physical phenomena, 
including perturbation theory of, for example an 
anharmonic oscillator, or non-linear optics. In the case of 
concentration dependent effects, higher order terms are 
commonly employed to account for intermolecular 
interactions, e.g. aggregation [37]. Similar to the liquid 
samples, the spectra collected from the 0.5 mg/mL 
samples have been inputted into the regression model, 
delivering a predicted value of 0.383 +/- 0.007 mg/mL.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: A: Mean ATR IR spectra collected from unprocessed 
whole human serum (a) and supplemented with 0.5 mg/mL, 1 
mg/mL, 2.5 mg/mL, 5 mg/mL, 7.5 mg/mL, 10 mg/mL, 17.5 
mg/mL, 25 mg/mL and 50 mg/mL of glycine (respectively b-j) 
- offset for clarity; B: Scatter plot from the PCA performed on 
ATR-IR spectra collected from the different solutions. Colour 
coding has been used to better identify the different groups of 
spectra. The top arrow indicates the distribution of the data 
across the scatter plot according to concentrations of glycine 
added; C: Loadings 1 and 2 corresponding to the PCA analysis 
performed on serum-based solutions (respectively blue and 
red); D: Polynomial regression fit of ATR-IR absorption versus 
concentration of glycine in whole human serum in solution. 
The plot represents the distance between each groups and the 
un-supplemented serum (0 mg/mL) calculated using the PC_1 
score from the PCA. 
 
The ATR-IR measurement setup used in this study is 
perfectly suited for the analysis of complex mixtures. 
The direct deposition of solutions onto the crystal would 
offer the two options to collect the data from the liquid 
samples or following air drying. Ultimately, high quality 
spectra capturing the overall chemical composition can 
be collected, as highlighted with the unprocessed data 
displayed in figure 1 and figure 3. Both approaches 
deliver predicted values in the range of the blinded 
samples tested, although they underestimate the real 
concentration. Although removing a dominant molecule 
such as H2O from the signal collected could be expected 
to enhance the relative contribution of other weaker 
bands, resulting in a better separation of the different 
data groups, only the standard deviation has been 
improved but the accuracy remains unacceptable. 
Although those results are encouraging, in the context of 
human serum analysis, the difficulty comes from  
 
 
 
 
 
 
 
 
 
 
 
 
 
10 F. Bonnier et al.: Serum LMWF analysis using ATR-IR spectroscopy 
 
Copyright line will be provided by the publisher 
 
 
 
 
 
 
 
 
 
 
 
 
unbalanced concentrations existing between the different 
constituents. For example, Albumin itself represents 
about 50% of the overall composition which, combined 
with other abundant proteins such as immunoglobulin, 
fibrinogen or transferrin, brings this number up to 90%. 
As a result, the LMWF of the serum represents only 1% 
of the total composition [21]. Therefore, similar to other 
approaches to identifying serum biomarkers, such as 
chromatography and mass spectroscopy [22], the 
potential of vibrational spectroscopy techniques could 
also be greatly improved when coupled with optimised 
sample preparation methods aiming to isolate the LMWF 
for more specific spectral characterisation.   
 
3.4 Centrifugal filtration and HMW protein 
depletion  
Mass spectroscopy is the most commonly reported 
technique for the recent investigations screening the 
LMWF for disease-related information, probing and 
profiling proteomic information of hundreds of candidate 
disease biomarkers without the need for a priori 
knowledge of their existence or relevance to disease 
states [39-41]. Facing the complexity of human serum, 
most approaches aiming for the identification and 
validation of LMWF diagnostic biomarkers have 
introduced HMWF depletion in their protocols [42]. 
Although ATR-IR spectroscopy is an attractive, rapid 
and cost effective alternative for the screening of patient 
samples in order to deliver a specific diagnostic, 
similarly to mass spectroscopy, the depletion of abundant 
proteins (HMWF) is a non-optional step in the 
investigation of the relevant fraction of the serum, in 
order to highlight and potentially target small circulating 
biomolecules. When applying vibrational spectroscopy 
techniques for rapid screening of human body fluids, 
numerous constraints towards the integrity of the 
samples need to be considered in order to provide an 
adapted and optimised methodology. While a wide range 
of chemical extraction/precipitation protocols of the 
HMWF can be found in the literature [43, 44], the impact 
of the solvents involved in the different steps is unclear, 
considering that most of them would exhibit strong IR 
features, contributing to the spectra collected, adding 
complexity to the identification of specific spectral 
variations in serum biomolecules. Commercially 
available centrifugal filtration devices such as the 
Amicon ultra-0.5 (Merk Millipore) provide, as stated by 
the manufacturer, “a fast ultrafiltration, with the 
capability for high concentration factors and easy 
concentrate recovery from the dilute and complex 
matrices”. This aspect has already been explored in 
previous studies which demonstrated that the 
concentrating factor of 10, when centrifuging human 
serum at 14000g for 30 mins, offers possibilities for 
analysing samples in liquid form with both IR and 
Raman spectroscopy [33]. The main advantage of this 
approach resides in the centrifugal separation of the 
molecules based on their sizes without the need for 
additional solvents, resulting in the preservation of the 
biomolecules from the serum as close as possible to their 
native forms. Another attractive aspect of the centrifugal 
centrifugation for biomedical applications is the 
possibility to collect both the concentrated HMW and the 
filtered LMW fractions. For instance, using a 10kDa cut-
off point, the depletion of abundant proteins with high 
molecular weight can be achieved, as only small 
biomolecules are able to freely pass through the 
membrane, providing a perfectly suited in vitro tool for 
quick separation of molecular species for subsequent 
spectroscopic characterisation [45].  
Evaluation of the efficiency of the HMW protein 
depletion has been performed based on size exclusion 
chromatography (Figure 6). The whole unprocessed 
human serum, presented in Figure 6A, has been used as 
reference in order to visualise the different features 
present and defined windows on the chromatogram 
corresponding to relevant elution times. The regions 
corresponding to the HMWF and LMWF have been 
highlighted and are respectively found between elution 
times of 9-15 mins and 19-22 mins. The dominant peak, 
positioned at 14 mins, corresponds to the contribution of 
albumin, the most abundant protein in human serum 
(Figure 6B). Comparison of the data collected from 
unprocessed (Figure 6A) and 10kDa filtered human 
serum samples (Figure 6C) clearly highlights a strong 
decrease in the intensities of the bands located in the 
HMWF window of the chromatogram. In order to enable 
a better estimation of the degree of depletion achieved, 
the Area Under the Curve (AUC) for the albumin peak 
was calculated. Considering the dilution factors used for 
the sample preparation, an average of 0.16% remaining 
albumin can be found in the samples following 
centrifugal filtration (Table 1). Although, only done in 
triplicates, the reproducibility of the HMW proteins 
depletion has been found quite acceptable with 
remaining percentages of albumin comprised between 
0% and 0.37%. According to the chromatogram, most of 
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the HMWF proteins are characterised by higher 
molecular masses, with elution times between 9-14 mins 
(Figure 6A). Therefore, an efficient depletion of the 
albumin would also impact on the other abundant 
proteins. Finally, the LMWF has been found to be totally 
preserved during the centrifugal filtration process. A 
similar AUC analysis for the peak located around 20 
mins, estimated values of 0.188 +/- 0.004 and 0.190+/-
0.012 for the whole unprocessed and the 10kDa filtered 
human serum respectively (Figure 6A and 6C).  
              
 
Figure 6: Size Exclusion Chromatography performed on A: 
Whole serum (1:50 dilution); B: Human serum albumin (1 
mg/mL); and C: Filtrate obtained from human serum after 
centrifugal filtration using a 10kDa device (serum diluted 1:10 
prior to centrifugation) and Chromatograms off set for clarity. 
The regions corresponding to the High Molecular Weight 
Fraction (HMWF) and the Low Molecular Weight Fraction 
(LMWF) have been highlighted. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1: Area Under the Curve (AUC) calculated for the 
albumin peak observed in the chromatograms displayed in 
figure 6. The percentage of Albumin (Alb) takes into account 
the dilution factors used for the sample preparation. 
 Whole serum Filtrate (10kDa) 
AUC (min-max) 0.4725 - 0.5048 0 – 0.0115 
AUC (average / 
STD) 
0.489 +/- 0.023 0.004 +/- 0.0053 
Vol injected (µl) 50 50 
Dilution factor 50 10 
% HSA (average) 100% (reference) 0.16% 
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3.5 Centrifugal filtration for human serum 
LMWF spectroscopic analysis   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: A: Mean ATR IR spectra collected from the 
ultrafiltetered human serum (a) and supplemented with 0.01 
mg/mL, 0.05 mg/mL, 0.1 mg/mL, 0.25 mg/mL, 0.5 mg/mL, 1 
mg/mL, 2 mg/mL and 2.5 mg/mL of glycine (respectively b-i)- 
offset for clarity; B: Scatter plot from the PCA performed on 
ATR-IR spectra collected from the different solutions. Colour 
coding has been used to better identify the different groups of 
spectra. The top arrow indicates the distribution of the data 
across the scatter plot according to concentrations of glycine 
added; C: Loadings 1 and 2 corresponding to the PCA analysis 
performed on serum solutions (respectively blue and red); D: 
Polynomial regression fit of ATR-IR absorption versus 
concentration of glycine in whole human serum in solution. 
The plot represents the distance between each groups and un-
supplemented serum (0 mg/mL) calculated using the PC1 score 
from the PCA. 
 
Following centrifugal filtration using 10kDa filters, the 
depletion of abundant proteins can be efficiently 
achieved as highlighted using exclusion chromatography. 
The removal of the HMWF will naturally have huge 
consequences on the IR spectra collected from the 
filtered part of the serum. The glycine, selected as a 
model, being the smallest amino acid, will freely pass 
through the centrifugal device membrane and be 
collected with the LMWF. Samples of whole serum and 
filtrates obtained from centrifugal filtration with 10kDa 
filters have been prepared by freeze drying and weighing 
of lyophilisates was performed to quantify the amounts.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In the present case, the serum stock solution used in this 
study has an initial concentration of 98.5 +/- 0.2 mg/mL, 
taking into account all molecular species naturally 
present in the serum, while, after processing with 
centrifugal filtration, the LMWF was found to be 13.3 
+/- 0.5 mg/mL. Therefore, the range of concentrations of 
glycine analysed for filtered human serum has been 
considerably reduced, extending from 0.01 mg/mL to 2.5 
mg/mL. The mean spectra collected from the different 
LMWF dry samples are presented in figure 7. Based on a 
similar approach to the one used previously on whole 
serum, the position for each group of data has been 
estimated according to the scores corresponding to PC 1 
(see equation 1) and a correlation curve has been drawn. 
Once again, the curve follows a polynomial pattern and a 
trend line can be fitted with R
2 
= 0.9981. Following 
depletion of the abundant proteins, the sensitivity for the 
detection of glycine has been considerably improved and 
the regression model built allows to deliver a predicted 
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value of 0.011 mg/mL +/- 0.006 mg/mL, for the 
0.01mg/mL sample. Although the standard deviation 
remains quite high compared to the average predicted 
value, the depletion of HMW proteins greatly enhanced 
the sensitivity of the method. The main limitations 
encountered remain purely technical, as both the LMWF 
fraction and the added glycine are particularly low in 
concentrations which make the data collected strongly 
influenced by the reproducibility of the drops deposited. 
A much lower standard deviation could easily be 
achieved using an automated system for deposition 
rather than micropipettes which could lead to 
uncertainties.     
          
3.6 Discussion 
The focus in the field of clinical serology has recently 
been shifted to an unexplored reservoir of potentially 
relevant biomolecules gathered in the LMWF of the 
proteome, incorporating their metabolic products 
(peptidome). While the LMWF serum peptidome has 
been dismissed as too small to be biologically relevant, it 
has been also been reported that this fraction may contain 
a rich, untapped source of disease-specific diagnostic 
information [45, 46]. The low molecular mass range 
(<10 kDa) remains largely uncharacterized but promises 
to contain a precious source of previously undiscovered 
biomarkers, mostly because it has now been recognized 
to contain shed proteins and protein fragments (clipped 
or cleaved) originating from physiologic and pathologic 
events taking place in all perfused tissues [44, 46, 47]. 
While the size of HMW proteins prevents them from 
entering the circulation, fragments from those could be 
found in the serum proteome, mixed with the normal 
constituents, the remaining challenge being to detect 
them among the broad molecular population.  
The metabolites are physiological constituents of the 
human serum LMWF that can potentially reflect a 
patient’s health status. Variations in their concentrations 
can be a good indicator to detect undergoing pathological 
processes, and therefore as physiological markers for 
rapid diagnostics. Glucose remains the most common 
example, but also one of most targeted molecules for the 
development of ex vivo quantitative models, notably IR 
spectroscopy [48, 49]. While the normal average 
concentration for glucose is roughly about 0.8 mg/mL 
[50], making its detection achievable in whole serum, 
monitoring and estimation of its blood levels based on 
spectral features will be significantly limited in the 
presence of highly abundant proteins (HMWF). With a 
molecular mass of 180 Da, glucose can freely pass 
through the 10kDa centrifugal devices used is this work 
and be collected entirely in the filtered fraction. That 
means blood glucose levels could be determined more 
accurately but also that the spectroscopic analysis could 
be used for patients with extremely low glucose levels 
located in the range of a few µg/mL, which is not 
achievable before HMWF depletion. Moreover, glucose 
remains one of the most abundant metabolites found in 
the human serum, which probably explains its recurrent 
apparition in the literature. The methodology proposed 
here opens numerous perspectives toward the broadening 
of applications as a direct consequence of the isolation of 
the LMWF to potentially reveal the contribution of 
numerous other metabolites which will fall within the 
lowered limit of detection range estimated [51]. For 
instance, most amino acids can be found naturally in the 
human serum, levels ranging from 0.262 mg/mL 
(proline), to 0.0132 mg/mL (alanine) to 0.024 mg/mL 
(glycine), 0.023 mg/mL (phenylalanine). Moreover, a 
large number of other metabolites with clinical potential 
for health monitoring can be found in human serum [50, 
51], including, as examples, lactate (acid base 
homeostasis), creatinine (renal health) or carnitine (heart 
dysfunction), with respective normal concentrations 
documented at 0.29 mg/mL, 0.009 mg/mL and 0.005 
mg/mL, respectively [51]. Many serum analytical 
techniques, for example, peptidomics, metabolomics etc. 
also require depletion of the HMWF. Centrifugation can 
processes many vials at the same time, and thus is much 
faster than for example chromatographic separation 
techniques. The study demonstrates the potential 
advantages of spectroscopic methods over the 
subsequent analysis techniques. Simplifying the serum 
composition by depletion could lead to the development 
of more suitable methods for in vitro diagnostics which, 
coupled to the considerable improvements made in 
recent years in the field of data preprocessing and 
analysis, will allow accurate and reproducible models for 
quantitative screening of key molecules present in the 
LMWF to be built.   
4.  Conclusion 
The rapid increase of scientific works referenced in the 
literature demonstrates the growing interest in translating 
and adapting the capabilities of vibrational spectroscopic 
techniques to the development of serological diagnostic 
methods. However, little or no consideration has been 
given to the protocols employed for sample preparation, 
leading to a poor relevancy of the outcomes due to the 
high degree of complexity of the serum. Although 
vibrational spectroscopy delivers the chemical 
fingerprint of the analyzed samples, with, in principle, 
contributions from all molecular species present, the 
limit of detection found experimentally would suggest 
that performing analysis on whole human serum will 
imply negligible contribution from numerous 
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constituents present at low concentrations. Human serum 
screening, and by extension all body fluids, is still an 
emerging field of application and in order to strengthen 
the position of Infrared and Raman spectroscopy as 
clinical tools, numerous questions need to be considered 
and addressed by the community, firstly, to be in 
accordance with other approaches currently used such as 
Mass spectroscopy and secondly, be able to deliver 
clinically relevant information for diagnosis. Adapting 
and optimizing sample preparation methods have a 
considerable impact on the sensitivity of the 
spectroscopic analysis of the LMWF of the human serum. 
The model built on glycine monitored by ATR-IR clearly 
demonstrates that removal of water, by drying, and the 
HMWF, by centrifugal filtration, leads to an 
improvement of the sensitivity of the technique which 
allowed to identify blinded concentrations of glycine up 
to 50 times lower compared to whole human serum.   
Furthermore, as the sample processing is also applicable 
to a wider range of body fluids, the methodology 
presented in the present work will certainly be beneficial 
for the field and lead to drastic improvements in the 
strategies oriented toward their implementation as the 
next generation of diagnostics techniques clinical tools.   
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Text:  
 
The Low Molecular Weight Fraction (LMWF) of serum holds 
great potential for diagnostics and health monitoring. The low 
concentrations of peptides and metabolites compared to highly 
abundant proteins remain a challenging obstacle to overcome. 
In order to collect specific chemical fingerprint from small 
serum biomolecules using vibrational spectroscopy techniques, 
High Molecular Weight (HMW) proteins depletion is required. 
Physical separation by mean of ultrafiltration offers a new 
dimension in serological diagnostic and further support the 
potential of Infrared and Raman spectroscopy as clinical tools.      
 
 
 
 
 
